Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …

Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and
molecular imaging (MI), including positron emission tomography (PET), single-photon …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of
neoplasms that vary in their histology, clinical features, prognosis, and management. The …

Simple Summary The monitoring of disease in patients with neuroendocrine tumors is
challenging and requires specialized imaging techniques. To address these quests …

Objective To establish a prediction model for preoperatively predicting grade 1 and grade
2/3 tumors in patients with pancreatic neuroendocrine tumors (PNETs) based on 68Ga …

We compared head-to-head the most used radiolabeled peptides for single photon
computed emission tomography (SPECT) and positron emission tomography (PET) imaging …

Neuroendocrine tumors (NETs) frequently overexpress somatostatin receptors (SSTR) on
their cell surface. The first-line pharmacological treatment for inoperable metastatic …

Pharmaceutical peptide Octreotide is a somatostatin analog with targeting and therapeutic
abilities. Over the last decades, Octreotide has been developed and approved to treat …

Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neoplasms that fall within the
category of neuroendocrine tumors. In the last decade, their diagnostic algorithm has been …